Skip to main content

Mary P. Bronner, MD


View Full Profile

Lisa A. Cannon-Albright, PhD


View Full Profile

Mingnan Chen, PhD


View Full Profile

Samuel H. Cheshier, MD, PhD


View Full Profile

Michael W. Deininger, MD, PhD


View Full Profile

Kimberley J. Evason, MD, PhD


View Full Profile

Gabriel C. Fine, MD


View Full Profile

Matthew A. Firpo, PhD


View Full Profile

Ahmad S. Halwani, MD


View Full Profile

Lewis Charles Murtaugh, PhD


View Full Profile

Deborah Wood Neklason, PhD


View Full Profile

Trudy G. Oliver, PhD


View Full Profile

Minna Roh-Johnson, PhD


View Full Profile

Cornelia Ulrich, PhD, MS


View Full Profile

Matthew W. VanBrocklin, PhD


View Full Profile

Katherine E. Varley, PhD


View Full Profile

Alana L. Welm, PhD


View Full Profile

Xinjian Chen

Xinjian Chen, MD, PhD

Assistant Professor - Pathology

We study targeted therapy in combination with immunotherapy for cancer treatment, using graphene oxide-formulated anticancer antibodies along with tumor-targeted delivery of immune cytokines. Our goal is to convert tumor necroptosis into tumor vaccine in situ to overcome intratumor tolerogenic microenvironment. We also investigate mechanisms of cancer cell necroptosis brought about by graphene oxide-formulation anticancer antibodies.

3i Bridge/Pillar: Cancer

Keywords: anticancer antibodies, graphene oxide, necroptosis

xinjian.chen@path.utah.edu